Rifapentine impurity reference standards are used by pharmaceutical quality-control laboratories, contract research organisations, and generic drug manufacturers to identify, quantify, and control Rifapentine-related impurities during analytical method development, method validation, and regulatory filing. As a rifamycin antibiotic, Rifapentine requires precise characterisation of its process impurities, degradation products, and related substances to meet European Pharmacopoeia (EP), United States Pharmacopeia (USP), and British Pharmacopoeia (BP) monograph requirements. Allmpus Laboratories manufactures and supplies a comprehensive library of Rifapentine impurity standards, each provided with a Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS). All products are held in-stock for rapid dispatch and are suitable for use in ANDA and DMF regulatory submissions.
Chemical Name: 3-[[(4-Cyclopentyl-1-piperazinyl)imino]m...
CAS No:
79039-56-8
Molecular Formula: C45H62N4O11
Molecular Weight: 834.99
CAT No:
ALL-RIF-DA
Keywords: SMILES string - OC(C(/C=N/N1CCN(C2CCCC2)...
Inventory Status:IN STOCK
Chemical Name: 1,2-dihydro-5,6,9,17,19,21-hexahydroxy-2...
CAS No:
16783-97-4
Molecular Formula: C36H45NO12
Molecular Weight: 683.75
CAT No:
ALL-R03982
Keywords: SMILES string - CC1CCC(OC1(C(=O)C(=O)N2C...
Inventory Status:IN STOCK
Chemical Name: 3-[[(4-Cyclopentyl-1-piperazinyl) imino]...
CAS No:
N.A
Molecular Formula: C47H64N4O13
Molecular Weight: 893.04
CAT No:
ALL-R03057
Keywords: SMILES string - [O-][N+]1(C2CCCC2)CCN(N=...
Inventory Status:IN STOCK
Chemical Name: Rifapentine Quinone
CAS No:
N.A
Molecular Formula: C47H62N4O12
Molecular Weight: 875.03
CAT No:
ALL-R06675
Keywords: SMILES string - O=C(/C(C)=C\C=C\[C@H](C)...
Inventory Status:IN STOCK
Allmpus Laboratories Private Limited, based in India, is engaged in the design, research, and cost-effective synthesis of API-related compounds, process impurities, and metabolites across a range of drug families, including the rifamycin class to which rifapentine belongs. Our synthesis and isolation/purification capabilities are developed to produce impurity standards suitable for analytical method development, method validation, and stability studies, supplied with characterization data appropriate for regulatory documentation needs. This supports clients working through ANDA and DMF filing processes as well as genotoxic impurity assessments where applicable.
Rifapentine is susceptible to oxidative degradation, forming related substances such as the N-oxide and quinone forms. Reference standards for these degradants are needed to demonstrate that an analytical method can distinguish the parent drug from its degradation products, as required for stability-indicating method validation.
Traceability to EP or USP reference standards can be provided where feasible, depending on the specific impurity and available pharmacopoeial monograph data. This should be confirmed with our technical team for the specific impurity and application in question.
No. These standards are supplied strictly for analytical and research purposes, including method development, validation, and quality control testing, and are not intended for human or veterinary administration.